The company had posted a net profit of Rs 4.04 billion in the year-ago period, Piramal Enterprises said in a filing to BSE.
Consolidated revenue from operations also rose to Rs 28.58 billion for the quarter under review, against Rs 23.41 billion in the same period a year ago.
Also Read
The consistency in the company's performance is an outcome of the robust business model and sharp focus on quality, compliance, legal and risk mitigation across the businesses, he added.
"Nearly Rs 7,000 crore of capital, which we are in the process of raising from existing and new top quality global and domestic investors, will play an instrumental role in achieving ambitious growth plans across our businesses operating in financial services and pharmaceutical sectors," Piramal said.
Shares of Piramal Enterprises were trading at Rs 2,783.40 per scrip on BSE, down 0.62 per cent from the previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)